A phase 3, randomized, three-arm, double-blind, active controlled, parallel group, multicenter trial to evaluate the safety and efficacy of muraglitazar in combination with metformin compared to glimepiride in combination with metformin in subjects with type 2 diabetes who have inadequate glycaemic control on metformin therapy alone
Phase of Trial: Phase III
Latest Information Update: 13 Sep 2010
At a glance
- Drugs Glimepiride; Muraglitazar
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- 22 Oct 2005 New trial record.